The following genes with mutational overrepresentation in metastatic samples also qualified as early metastatic drivers: TP53, RB1, CTNNB1, and DCHS2. These genes might be suitable markers for disease progression, as they are likely metastatic drivers and they are already detectable in the primary tumor. The gene discussed is TP53; the disease is neoplasm.